Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NH002 (Perflutren Lipid Microspheres) dose escalation in cardiac echocardiography
NCT04185246Phase 2Completed
- Sponsor
- Trust Bio-sonics Inc.
- Start
- Nov 2019
- Primary completion
- Jul 2020
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren lipid microspheres, sponsored by Trust Bio-sonics Inc.. Started Nov 2019; status: completed.
02
Drugs
perflutren lipid microspheres
Beyond the preview
Go deeper on NCT04185246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04185246.